| Autor: |
Smith P; USC School of Medicine Greenville, Greenville, South Carolina, USA., Snyder B; Indiana University School of Medicine, Indianapolis, Indiana, USA., McDaniel M; USC School of Medicine Greenville, Greenville, South Carolina, USA.; Department of Pediatrics, Prisma Health Upstate Children's Hospital, Greenville, South Carolina, USA., St Ville M; Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland, USA., Cull E; USC School of Medicine Greenville, Greenville, South Carolina, USA.; Prisma Health Cancer Institute, Greenville, South Carolina, USA., Siembida EJ; Institute of Health Science, Northwell Health, Manhasset, New York, USA., Saha A; USC School of Medicine Greenville, Greenville, South Carolina, USA.; Department of Pediatrics, Prisma Health Upstate Children's Hospital, Greenville, South Carolina, USA. |
| Abstrakt: |
Purpose: Despite improvements in survival, adolescent and young adult (AYA) oncology patients are at high risk for experiencing negative health-related quality of life (HRQOL) outcomes. AYA cancer programs have attempted to develop assessment tools to identify areas of need. We aimed to demonstrate the feasibility/utility of the Patient-Reported Outcome Measurement Information System ® -29 (PROMIS ® -29) within an AYA oncology program clinic. Methods: AYA patients were referred by oncologists to the AYA oncology program at Prisma Health. The PROMIS-29 v2.0 survey was administered to AYAs at point of care. Feasibility of distribution and completion rate of surveys were determined. PROMIS surveys were self-reported and subsequently scored using standardized methods. The domains assessed included physical function, anxiety, depression, fatigue, sleep disturbance, ability to participate in social roles/activities, pain interference, and pain intensity. Qualitative descriptions of AYA care delivery based on survey responses at the patient level and programmatic level are also presented. Results: Between May 2017 and 2019, 134 AYAs who were newly diagnosed or in treatment completed the survey. Distribution and completion rates for the PROMIS-29 were both 100%, and meaningful changes in program-level services were implemented as a result of PROMIS-29 score patterns. Within the entire cohort, T-scores for anxiety, fatigue, and physical function reached clinically relevant thresholds. Conclusion: PROMIS offers a feasible opportunity for AYA programs to measure clinically useful HRQOL outcomes in AYAs. The survey can be used to deliver real-time AYA care to recently diagnosed and in-treatment AYAs and make programmatic changes within AYA oncology programs. |
